期刊文献+

耐药乳腺癌免疫治疗的实验研究 被引量:2

Pilot Study of Immunization Therapy on Drug-Resistance in Breast Cancer Bearing Mouse Model
下载PDF
导出
摘要 目的:探讨耐药乳腺癌抗原负载的树突细胞(DC)与细胞因子诱导的杀伤细胞(CIK)联合培养后对同种乳腺癌荷瘤小鼠的可能治疗机制。方法:分离健康人外周血获得单个核细胞,分别诱导为DC和CIK细胞,将人类乳腺癌耐药细胞株MCF-7/ADR细胞的冻融物抗原冲击DC(AP-DC),分别将DC与CIK细胞共培养(AP-DC+CIK组、DC+CIK组),将细胞经尾静脉注入裸鼠体内,观察不同组荷瘤标本中MDR1的表达、肿瘤细胞凋亡及凋亡相关蛋白Bax和Bcl-2的表达。结果:AP-DC+CIK组、DC+CIK组、CIK组及生理盐水组MDR1/β-actin比值分别为0.14、0.57、0.81及0.98。生理盐水组、CIK组、DC+CIK组和AP-DC+CIK组平均凋亡指数差异有统计学意义(P<0.001)。各组Bcl-2及Bax蛋白表达的OD值差异有统计学意义(P<0.01),Bcl-2/Bax值AP-DC+CIK组<DC+CIK组<CIK组<生理盐水组。结论:经耐药乳腺癌抗原负载的DC与CIK共同作用后,诱导同种乳腺癌细胞凋亡强于单纯DC与CIK共同作用后及单独CIK的治疗效果。 Objective: To explore the possible mechanisms of immunization therapy, cytokine-induced killer (CIK) cells co-cultured with dendritic cells (DC), on mutidrug-resistance breast cancer bearing mouse model. Methods: DC and CIK were cultured respectively from peripheral blood mononuclear cells (PBMC) derived from healthy individuals. MCF-7/ ADR, a kind of breast cancer cell line with multidrug resistance, was prepared to obtain the antigen lyses. CIK was co-cul- tured with DC pulsed or unpulsed by the above antigen lyses (AP-DC+CIK and DC+CIK). The effector cells were injected into the tumor-bearing mice through tail intravenous. The expression of MDR1, tumor cell apoptosis and the expression of Bcl-2 and Bax were measured in 4 types of cells. Results:The ratio of MDR1 to β-actin was different in the above 4 types of cells, AP-DC+CIK group was 0.14, DC+CIK group was 0.57, CIK groupwas 0.81, and normal saline (NS) group was 0.98. The average apoptosis index was also significantly different in these 4 groups (P 〈 0.001). The values of optical density (OD) of protein Bcl-2 and Bax were different in 4 types of cells (P 〈 0.05). The value of Bcl-2/Bax was the lowest in AP-DC+CIK group, and then followed by DC+CIK group and CIK group. The value of Bcl-2/Bax was the highest in NS group. Conclu- sion: After CIK cells were co-cultured with DC loaded with multidrug resistance breast cancer antigen, the apoptosis of these breast cancer cells was higher than those of CIK cells co-cultured with DC and those of CIK.
出处 《天津医药》 CAS 北大核心 2012年第4期359-362,I0004,共5页 Tianjin Medical Journal
基金 天津市自然科学基金资助项目(项目编号:09JCYBJC10600)
关键词 树突细胞 杀伤细胞 淋巴因子激活 BCL-2相关X蛋白质 乳腺肿瘤 抗药性 肿瘤 疾病模型 动物 dendritic cells killer cells, lymphokine-activated bcl-2-associated X protein breast neoplasms drug resistance, neoplasm disease models, animal
  • 相关文献

参考文献15

  • 1庞华,司玉玲,綦振家,王英娟,王亮,李世俊.耐药乳腺癌裸鼠模型免疫治疗初探[J].天津医药,2011,39(12):1136-1140. 被引量:7
  • 2鲍锋,盛春华,杨光.DC-CIK细胞治疗中晚期恶性肿瘤531例分析[J].中国免疫学杂志,2011,27(4):360-362. 被引量:34
  • 3姚春,宋善俊.脐血CIK细胞对耐药白血病细胞体外杀伤效应及其机制的研究[J].临床血液学杂志,2008,21(4):369-372. 被引量:11
  • 4Gupta S,Kass GE,Szegezdi E. The mitochondrial death pathway:A promising therapeutic target in Diseases[J].Journal of Cellular and Molecular Medicine,2009,(06):1004-1033.
  • 5Kowalczyk JE,Zablocka B. Protein kinases in mitochondria[J].Postepy Biochemii,2008,(02):209-216.
  • 6Brunelle JK,Letai A. Control of mitochondrial apoptosis by the Bcl-2 family[J].Journal of Cell Science,2009,(Pt4):437-441.
  • 7Korsmeyer SJ,Shutter JR,Veis DJ. Bcl-2/Bax:a rheostat that regulates an anti-oxidant pathway and cell death[J].Seminars in Cancer Biology,1993,(06):327-332.
  • 8Knudson CM,Brown NM. Mitochondria potential,Bax"activation",and programmed cell death[J].Methods in Molecular Biology,2008.95-108.
  • 9Yu J,Zhang W,Jiang H. CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to Fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-γ stimulation[J].Cancer Biotherapy and Radiopharmaceuticals,2008,(03):342-354.
  • 10Ren X,Yu J,Liu H. Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients[J].Cancer Biotherapy and Radiopharmaceuticals,2006,(01):22-33.

二级参考文献39

共引文献54

同被引文献22

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部